Publications by authors named "Ana Vera"

Claim this Profile
M
Mineralocorticoid receptor antagonism of vamorolone: Evidence from LIONHEART and VISION-DMD clinical trials.
Ana de Vera, Paula R Clemens, Utkarsh J Dang, Catherine Dutreix, Ekaterina Gresko

Steroids· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Essential Oils Can Mitigate Adverse Effects of Prolonged Masking in the Hospital Setting.
Jan E Patterson, Rebekah Kendrick, Camerino I Salazar, Ana Vera, Michael G MacNaughton

Holist Nurs Pract· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improving the Safety, Effectiveness, and Efficiency of Clinical Alarm Systems: Simulation-Based Usability Testing of Physiologic Monitors.
Azizeh K Sowan, Nancy Staggers, Andrea Berndt, Tommye Austin, Charles C Reed, Ana Vera

JMIR Nurs· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Paramagnetic Ionic Liquid/Metal Organic Framework Composites for CO/CH and CO/N Separations.
Tiago J Ferreira, Ana T Vera, Beatriz A de Moura, Laura M Esteves, Mohammad Tariq

Front Chem· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and validation of a Bayesian survival model for inclusion body myositis.
Gorana Capkun, Jens Schmidt, Shubhro Ghosh, Harsh Sharma, Thomas Obadia, Ana de Vera

Theor Biol Med Model· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and efficacy of intravenous bimagrumab in inclusion body myositis (RESILIENT): a randomised, double-blind, placebo-controlled phase 2b trial.
Michael G Hanna, Umesh A Badrising, Olivier Benveniste, Thomas E Lloyd, Merrilee Needham, Ana de Vera

Lancet Neurol· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transcription Errors of Blood Glucose Values and Insulin Errors in an Intensive Care Unit: Secondary Data Analysis Toward Electronic Medical Record-Glucometer Interoperability.
Azizeh Khaled Sowan, Ana Vera, Ashwin Malshe, Charles Reed

JMIR Med Inform· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Secukinumab is Superior to Ustekinumab in Clearing Skin in Patients with Moderate to Severe Plaque Psoriasis (16-Week CLARITY Results).
Jerry Bagel, John Nia, Peter W Hashim, Manmath Patekar, Ana de Vera

Dermatol Ther (Heidelb)· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nurse Competence on Physiologic Monitors Use: Toward Eliminating Alarm Fatigue in Intensive Care Units.
Azizeh K Sowan, Ana G Vera, Elma I Fonseca, Charles C Reed, Albert F Tarriela

Open Med Inform J· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term results from a phase 2 extension study of fingolimod at high and approved dose in relapsing multiple sclerosis.
Xavier Montalban, Giancarlo Comi, Jack Antel, Paul O'Connor, Ana de Vera

J Neurol· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correlation between brain volume loss and clinical and MRI outcomes in multiple sclerosis.
Ernst-Wilhelm Radue, Frederik Barkhof, Ludwig Kappos, Till Sprenger, Dieter A Häring, Ana de Vera

Neurology· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The influence of patient demographics, disease characteristics and treatment on brain volume loss in Trial Assessing Injectable Interferon vs FTY720 Oral in Relapsing-Remitting Multiple Sclerosis (TRANSFORMS), a phase 3 study of fingolimod in multiple sclerosis.
Frederik Barkhof, Remko de Jong, Nikolaos Sfikas, Ana de Vera, Gordon Francis

Mult Scler· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fingolimod in relapsing multiple sclerosis: An integrated analysis of safety findings.
Ludwig Kappos, Jeffrey Cohen, William Collins, Ana de Vera, Lixin Zhang-Auberson

Mult Scler Relat Disord· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Congenital smooth muscle hamartoma of the palpebral conjunctiva.
L Evelyn Mora, Abelardo A Rodríguez-Reyes, Ana M Vera, Rosa Isela Rubio, Mariana Mayorquín-Ruiz

Ophthalmic Plast Reconstr Surg· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of fingolimod therapy on magnetic resonance imaging outcomes in patients with multiple sclerosis.
Ernst-Wilhelm Radue, Paul O'Connor, Chris H Polman, Reinhard Hohlfeld, Peter Calabresi, Ana de Vera

Arch Neurol· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oral fingolimod or intramuscular interferon for relapsing multiple sclerosis.
Jeffrey A Cohen, Frederik Barkhof, Giancarlo Comi, Hans-Peter Hartung, Bhupendra O Khatri, Ana de Vera

N Engl J Med· February 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antioxidant activity of edible fungi (truffles and mushrooms): losses during industrial processing.
M Antonia Murcia, Magdalena Martínez-Tomé, Antonia M Jiménez, Ana M Vera, Mario Honrubia

J Food Prot· October 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis